Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vanda Pharmaceuticals Inc...

    NASDAQ: VNDA · Real-Time Price · USD
    4.72
    -0.06 (-1.26%)
    At close: Jun 30, 2025, 3:59 PM
    4.72
    -0.13%
    After-hours: Jun 30, 2025, 05:25 PM EDT

    Vanda Pharmaceuticals Statistics

    Share Statistics

    Vanda Pharmaceuticals has 58.93M shares outstanding. The number of shares has increased by 1.11% in one year.

    Shares Outstanding

    n/a
    		 58.93M

    Shares Change (YoY)

    n/a
    		 1.11%

    Shares Change (QoQ)

    n/a
    		 1.06%

    Owned by Institutions (%)

    n/a
    		 73.72%

    Shares Floating

    n/a
    		 54.89M

    Failed to Deliver (FTD) Shares

    n/a
    		 8,991

    FTD / Avg. Volume

    n/a
    		 1.66%

    Short Selling Information

    The latest short interest is 4.73M, so 8.02% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.73M

    Short % of Shares Out

    n/a
    		 8.02%

    Short % of Float

    n/a
    		 8.32%

    Short Ratio (days to cover)

    n/a
    		 11.39

    Valuation Ratios

    The PE ratio is -14.74 and the forward PE ratio is -12.27. Vanda Pharmaceuticals's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -14.74

    Forward PE

    n/a
    		 -12.27

    PS Ratio

    n/a
    		 1.4

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 0.52

    P/FCF Ratio

    n/a
    		 -17.14

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Vanda Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 4.39

    Quick Ratio

    n/a
    		 4.37

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.38

    Debt / FCF

    n/a
    		 -0.76

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $540,141.3

    Profits Per Employee

    n/a
    		 $-51,358.7

    Employee Count

    n/a
    		 368

    Asset Turnover

    n/a
    		 0.3

    Inventory Turnover

    n/a
    		 6.56

    Taxes

    Income Tax

    n/a
    		 -4.02M

    Effective Tax Rate

    n/a
    		 17.54%

    Stock Price Statistics

    The stock price has increased by -15.41% in the last 52 weeks. The beta is 0.67, so Vanda Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.67

    52-Week Price Change

    n/a
    		 -15.41%

    50-Day Moving Average

    n/a
    		 4.4

    200-Day Moving Average

    n/a
    		 4.63

    Relative Strength Index (RSI)

    n/a
    		 59.65

    Average Volume (20 Days)

    n/a
    		 541,698

    Income Statement

    In the last 12 months, Vanda Pharmaceuticals had revenue of 198.77M and earned -18.9M in profits. Earnings per share was -0.33.

    Revenue

    n/a
    		 198.77M

    Gross Profit

    n/a
    		 187.46M

    Operating Income

    n/a
    		 -40.66M

    Net Income

    n/a
    		 -18.9M

    EBITDA

    n/a
    		 -32.53M

    EBIT

    n/a
    		 -40.66M

    Earnings Per Share (EPS)

    n/a
    		 -0.33
    Full Income Statement

    Balance Sheet

    The company has 102.32M in cash and 12.36M in debt, giving a net cash position of 89.96M.

    Cash & Cash Equivalents

    n/a
    		 102.32M

    Total Debt

    n/a
    		 12.36M

    Net Cash

    n/a
    		 89.96M

    Retained Earnings

    n/a
    		 -174.29M

    Total Assets

    n/a
    		 631.94M

    Working Capital

    n/a
    		 303.99M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -15.76M and capital expenditures -490K, giving a free cash flow of -16.25M.

    Operating Cash Flow

    n/a
    		 -15.76M

    Capital Expenditures

    n/a
    		 -490K

    Free Cash Flow

    n/a
    		 -16.25M

    FCF Per Share

    n/a
    		 -0.28
    Full Cash Flow Statement

    Margins

    Gross margin is 94.31%, with operating and profit margins of -20.46% and -9.51%.

    Gross Margin

    n/a
    		 94.31%

    Operating Margin

    n/a
    		 -20.46%

    Pretax Margin

    n/a
    		 -11.53%

    Profit Margin

    n/a
    		 -9.51%

    EBITDA Margin

    n/a
    		 -16.36%

    EBIT Margin

    n/a
    		 -20.46%

    FCF Margin

    n/a
    		 -8.17%

    Dividends & Yields

    VNDA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VNDA is $16.5, which is 249.6% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $16.5

    Price Target Difference

    n/a
    		 249.6%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.35

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist